Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Constantin Lapa

Showing results (191-200 of 269) with videos related to

Pageof 27
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 20, 2016
68Ga-DOTATATE PET/CT Interobserver Agreement for Neuroendocrine Tumor Assessment: Results of a Prospective Study on 50 PatientsWolfgang Peter Fendler, Martin Barrio, Claudio Spick, et al.
EJNMMI Research|August 21, 2021
Investigation of spleen CXCR4 expression by [<sup>68</sup>Ga]Pentixafor PET in a cohort of 145 solid cancer patientsRichard Lewis, Stefan Habringer, Malte Kircher, et al.
JAMA Network Open|April 21, 2021
Accuracy of 18-F Fluorodeoxyglucose Positron Emission Tomographic/Computed Tomographic Imaging in Primary Staging of Squamous Cell Carcinoma of the Oral CavityChristian Linz, Roman C Brands, Theresia Herterich, et al.
Clinical Nuclear Medicine|July 6, 2019
Clinical Utility of Different Approaches for Detection of Late Pseudoprogression in Glioblastoma With O-(2-[18F]Fluoroethyl)-L-Tyrosine PETOlivia Kertels, Milena I Mihovilovic, Thomas Linsenmann, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 4, 2018
Prognostic value of [<sup>18</sup>F]FDG-PET/CT in multiple myeloma patients before and after allogeneic hematopoietic cell transplantationAntje Stolzenburg, Katharina Lückerath, Samuel Samnick, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 18, 2015
Biodistribution and radiation dosimetry for a probe targeting prostate-specific membrane antigen for imaging and therapyKen Herrmann, Christina Bluemel, Martina Weineisen, et al.
Endocrine|May 4, 2016
Assessment of tumor heterogeneity in treatment-naïve adrenocortical cancer patients using (18)F-FDG positron emission tomographyRudolf A Werner, Matthias Kroiss, Masatoyo Nakajo, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 13, 2021
Improved Primary Staging of Marginal-Zone Lymphoma by Addition of CXCR4-Directed PET/CTJohannes Duell, Franziska Krummenast, Andreas Schirbel, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 14, 2017
Predictive Value of <sup>18</sup>F-FDG PET in Patients with Advanced Medullary Thyroid Carcinoma Treated with VandetanibRudolf A Werner, Jan-Stefan Schmid, Takahiro Higuchi, et al.
Clinical Nuclear Medicine|February 15, 2019
Novel Functional Renal PET Imaging With 18F-FDS in Human SubjectsRudolf A Werner, Alvaro A Ordonez, Julian Sanchez-Bautista, et al.
Pageof 27

Showing results (191-200 of 269) with videos related to

Sort By:
Pageof 27
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 20, 2016
68Ga-DOTATATE PET/CT Interobserver Agreement for Neuroendocrine Tumor Assessment: Results of a Prospective Study on 50 PatientsWolfgang Peter Fendler, Martin Barrio, Claudio Spick, et al.
EJNMMI Research|August 21, 2021
Investigation of spleen CXCR4 expression by [<sup>68</sup>Ga]Pentixafor PET in a cohort of 145 solid cancer patientsRichard Lewis, Stefan Habringer, Malte Kircher, et al.
JAMA Network Open|April 21, 2021
Accuracy of 18-F Fluorodeoxyglucose Positron Emission Tomographic/Computed Tomographic Imaging in Primary Staging of Squamous Cell Carcinoma of the Oral CavityChristian Linz, Roman C Brands, Theresia Herterich, et al.
Clinical Nuclear Medicine|July 6, 2019
Clinical Utility of Different Approaches for Detection of Late Pseudoprogression in Glioblastoma With O-(2-[18F]Fluoroethyl)-L-Tyrosine PETOlivia Kertels, Milena I Mihovilovic, Thomas Linsenmann, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 4, 2018
Prognostic value of [<sup>18</sup>F]FDG-PET/CT in multiple myeloma patients before and after allogeneic hematopoietic cell transplantationAntje Stolzenburg, Katharina Lückerath, Samuel Samnick, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 18, 2015
Biodistribution and radiation dosimetry for a probe targeting prostate-specific membrane antigen for imaging and therapyKen Herrmann, Christina Bluemel, Martina Weineisen, et al.
Endocrine|May 4, 2016
Assessment of tumor heterogeneity in treatment-naïve adrenocortical cancer patients using (18)F-FDG positron emission tomographyRudolf A Werner, Matthias Kroiss, Masatoyo Nakajo, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 13, 2021
Improved Primary Staging of Marginal-Zone Lymphoma by Addition of CXCR4-Directed PET/CTJohannes Duell, Franziska Krummenast, Andreas Schirbel, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 14, 2017
Predictive Value of <sup>18</sup>F-FDG PET in Patients with Advanced Medullary Thyroid Carcinoma Treated with VandetanibRudolf A Werner, Jan-Stefan Schmid, Takahiro Higuchi, et al.
Clinical Nuclear Medicine|February 15, 2019
Novel Functional Renal PET Imaging With 18F-FDS in Human SubjectsRudolf A Werner, Alvaro A Ordonez, Julian Sanchez-Bautista, et al.
Pageof 27